Purchase this article with an account.
Hui-Ju Lin, Lei Wan, Wen-Chi Chen, Jane-Ming Lin, Chao-Jen Lin, Fuu-Jen Tsai; Muscarinic Acetylcholine Receptor 3 Is Dominant in Myopia Progression. Invest. Ophthalmol. Vis. Sci. 2012;53(10):6519-6525. doi: 10.1167/iovs.11-9031.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Numerous studies have proven that the nonselective muscarinic acetylcholine receptor (mAChR) antagonist atropine prevents the axial elongation that leads to myopia. Five distinct receptor genes (CHRM1–CHRM5), each encoding a muscarinic receptor protein (M–M), have been cloned. Copy number variations (CNVs), which constitute a substantial portion of genetic variability and structural genetic variants, are increasingly being recognized as modulators of human diseases. In this study, CNVs of CHRMs were detected to determine the genes associated with myopia.
Participants were divided into three groups: high myopia group (myopia of 6–10 diopters [D]), severe high myopia group (myopia ≥10 D), and control group (myopia ≤0.5 D). The CNVs were detected, and the relative copy number was estimated using the comparative 2−ΔΔCt method. Syrian hamsters with form-deprivation myopia (FDM) were used as animal models of myopia.
The CNVs of CHRM2, CHRM3, and CHRM4 were significantly different among the groups, and the variations were most dominant in the CHRM3. The CNVs of CHRM3 showed significant differences among all 3 groups (P = 0.005). A replication cohort was collected to further confirm the association of CHRM3 CNV with myopia (P = 0.011). The expression of M(3) on the sclera of the FDM Syrian hamsters was upregulated and then downregulated after atropine administration.
CHRM3 and M(3) were suggested to play important roles in the pathogenesis of myopia and in the arrested progression of myopia by atropine.
This PDF is available to Subscribers Only